According to recent studies with large cohorts, the risk of developing PD and the severity of the clinical features of these patients (age at onset, motor phenotype, neuropsychiatric symptoms, cognitive dysfunction, mortality, etc.)may be associated with the severity of GBA mutation. This evidence concerns the gene GBA1 and Parkinson disease.